Alangium lamarckii Thw.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | A. salviifolium (Linn. f.) Wang. |
| Family | Alangiaceae. |
| Habitat | The drier parts of India, in plains and foothills of southern India. |
| Ayurvedic | Ankola, Ankota, Taamraphala, Guptasneha, Dirghakeelaka. |
| Siddha / Tamil | Azinjil. |
| Action | Rootbark—astringent, spasmolytic, hypotensive, also diaphoretic and antipyretic. Leaves— hypoglycaemic. Fruits—acidic, astringent, laxative and refrigerant. Used in haemorrhages, strangury and consumption. The bark is used as a substitute for Cephaelis ipecacuanha. It is a rich source of alkaloids structurally related to ipecac alkaloids (emetin). |
| Dosage | Rootbark—1–2 g powder. (CCRAS.) |
| Taxonomic Cohort | Genus Alangium (2 documented species); Family Alangiaceae (2 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Alangium lamarckii (taxonomically cited with authority Thw.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Alangiaceae (primary family classification: Alangiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy A. salviifolium (Linn. f.) Wang, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: The drier parts of India, in plains and foothills of southern India.
Across classical and vernacular Indian systems of medicine, Alangium lamarckii is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Ankola, Ankota, Taamraphala, Guptasneha, Dirghakeelaka; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Azinjil. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Alangium lamarckii are: Rootbark—astringent, spasmolytic, hypotensive, also diaphoretic and antipyretic. Leaves— hypoglycaemic. Fruits—acidic, astringent, laxative and refrigerant. Used in haemorrhages, strangury and consumption. The bark is used as a substitute for Cephaelis ipecacuanha. It is a rich source of alkaloids structurally related to ipecac alkaloids (emetin). These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Alangium lamarckii establish the following evidence base: The bark contains the alkaloid alangine which shows a selective action of the parasympathetic mechanism, the action being more marked on gastrointestinal tract. The root extract shows hypotensive action. Flowers contain deoxytubulosine, a potent antiplatelet aggregation component, which has a strong binding with DNA. The plant extract possesses antineoplastic properties.

Botanical Reference 1: Alangium lamarckii — Wikimedia Commons

Botanical Reference 2: Alangium lamarckii — Wikimedia Commons
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Alangium comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Alangium begoniaefolium (Action: Bark and roots—sedative, anthelmintic). Comparing Alangium lamarckii alongside its congeners in genus Alangium highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Alangiaceae encompasses 2 documented medicinal species (0.11% of the 1,814-species flora). Other representative medicinal members of Alangiaceae include: Alangium begoniaefolium (Ankola). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 2 medicinal species of family Alangiaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Alangium lamarckii are prescribed as follows: Rootbark—1–2 g powder. (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Alangium lamarckii integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.